CIK: 0001535610
Total reported value
$45.1M
Showing top 200 holdings (of 307 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 14.37% | — | — | |
| 2 | ✓ | Sarepta Therapeutics INC | Stock-Other | 10.91% | — | -8.55% | |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | Stock-Healthcare | 4.79% | — | +54.48% | |
| 4 | HCA | HCA Healthcare, Inc. | Stock-Healthcare | 3.86% | — | -17.34% | |
| 5 | AMGN | Amgen Inc. | Stock-Healthcare | 2.85% | — | — | |
| 6 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 2.19% | — | -31.55% | |
| 7 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 2.03% | — | +6.14% | |
| 8 | ✓ | Alkermes PLC | Stock-Other | 1.87% | — | +143.37% | |
| 9 | MRK | Merck & Co., Inc. | Stock-Healthcare | 1.86% | — | — | |
| 10 | ✓ | Acadia Healthcare Company In | Stock-Other | 1.64% | — | — | |
| 11 | AMGN | Amgen INC | Stock-Healthcare | 1.48% | — | -13.57% | |
| 12 | ✓ | Agios Pharmaceuticals INC | Stock-Other | 1.44% | — | — | |
| 13 | SRPT | Sarepta Therapeutics, Inc. | Stock-Healthcare | 1.44% | — | -76.84% | |
| 14 | ABT | Abbott Laboratories | Stock-Healthcare | 1.40% | — | — | |
| 15 | ✓ | Clovis Oncology INC | Stock-Other | 1.40% | — | +259.78% | |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | Stock-Healthcare | 1.13% | — | +221.02% | |
| 17 | ✓ | Cempra INC | Stock-Other | 1.02% | — | +170.21% | |
| 18 | ✓ | Retrophin INC | Stock-Other | 0.94% | — | -33.37% | |
| 19 | ✓ | Puma Biotechnology INC | Stock-Other | 0.90% | — | +341.27% | |
| 20 | ✓ | Shire Plc-adr | Stock-Other | 0.90% | — | — | |
| 21 | ✓ | Shire Plc-adr | Stock-Other | 0.90% | — | — | |
| 22 | ✓ | Spdr Series Trust | Stock-Other | 0.86% | — | +5.38% | |
| 23 | ✓ | United Therapeutics CORP Del | Stock-Other | 0.86% | — | — | |
| 24 | HUM | Humana Inc. | Stock-Healthcare | 0.82% | — | — | |
| 25 | AXP | American Express Company | Stock-Financials | 0.79% | — | — | |
| 26 | AZN | AstraZeneca PLC | Stock-Healthcare | 0.77% | — | — | |
| 27 | ✓ | Lexicon Pharmaceuticals INC | Stock-Other | 0.75% | — | +17.73% | |
| 28 | HESM | Hess Midstream LP | Stock-Other | 0.73% | — | — | |
| 29 | ✓ | Depomed INC Cmn Stock | Stock-Other | 0.72% | — | +448.35% | |
| 30 | ✓ | Mylan N V | Stock-Other | 0.71% | — | — | |
| 31 | ✓ | Dynavax Technologies CORP | Stock-Other | 0.70% | — | -6.80% | |
| 32 | ✓ | Alnylam Pharmaceuticals INC | Stock-Other | 0.65% | — | +46.71% | |
| 33 | ✓ | Oncobiologics INC | Stock-Other | 0.64% | — | +9.65% | |
| 34 | ✓ | Bluebird Bio INC | Stock-Other | 0.62% | — | — | |
| 35 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.56% | — | — | |
| 36 | ✓ | Dynavax Technologies CORP | Stock-Other | 0.53% | — | +28.37% | |
| 37 | ✓ | Ionis Pharmaceuticals INC | Stock-Other | 0.53% | — | -39.69% | |
| 38 | ✓ | Clovis Oncology INC | Stock-Other | 0.50% | — | +1930.10% | |
| 39 | ✓ | Horizon Pharma Ord | Stock-Other | 0.49% | — | +85.40% | |
| 40 | ✓ | Achillion Pharmaceuticals In | Stock-Other | 0.49% | — | +136.19% | |
| 41 | ✓ | Cempra INC | Stock-Other | 0.49% | — | +96.42% | |
| 42 | ✓ | Tenet Healthcare CORP | Stock-Other | 0.48% | — | +3824.69% | |
| 43 | ✓ | Amicus Therapeutics INC | Stock-Other | 0.47% | — | +20.52% | |
| 44 | DXC | DXC Technology Company | Stock-Tech | 0.47% | — | -31.69% | |
| 45 | ✓ | Ophthotech CORP | Stock-Other | 0.46% | — | +320.22% | |
| 46 | ✓ | Exelixis INC | Stock-Other | 0.46% | — | — | |
| 47 | ✓ | Kite Pharma INC | Stock-Other | 0.44% | — | — | |
| 48 | ✓ | Axovant Sciences LTD | Stock-Other | 0.44% | — | — | |
| 49 | ✓ | Lion Biotechnologies INC | Stock-Other | 0.43% | — | +4.98% | |
| 50 | ✓ | Neurocrine Biosciences INC | Stock-Other | 0.41% | — | +49.32% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Sarepta Therapeutics INC | +3.2% | -8.55% | Trim |
| 2 | ✓ | Spdr S&p 500 ETF Tr | +2.1% | +66.37% | Add |
| 3 | ✓ | Celgene CORP | +1% | +396.55% | Add |
| 4 | ✓ | Celgene CORP | +0.9% | +3036.36% | Add |
| 5 | ✓ | Clovis Oncology INC | +0.7% | +259.78% | Add |
| 6 | ✓ | Alkermes PLC | +0.7% | +143.37% | Add |
| 7 | REGN | Regeneron Pharmaceuticals, Inc. | +0.6% | +54.48% | Add |
| 8 | SRPT | Sarepta Therapeutics INC | +0.5% | -31.55% | Trim |
| 9 | ✓ | Puma Biotechnology INC | +0.4% | +341.27% | Add |
| 10 | VRTX | Vertex Pharmaceuticals Incorporated | +0.4% | +221.02% | Add |
| 11 | ✓ | Cempra INC | +0.4% | +170.21% | Add |
| 12 | ✓ | Depomed INC Cmn Stock | +0.3% | +448.35% | Add |
| 13 | ✓ | Clovis Oncology INC | +0.3% | +1930.10% | Add |
| 14 | ✓ | Novavax INC Cmn Stock | -0.4% | -91.92% | Trim |
| 15 | ✓ | Retrophin INC | -0.4% | -91.69% | Trim |
| 16 | ✓ | Medicines Company | -0.5% | -68.18% | Trim |
| 17 | ✓ | Sage Therapeutics INC | -0.5% | -92.42% | Trim |
| 18 | ✓ | Mannkind CORP Common Stock | -0.8% | +17.60% | Add |
| 19 | ✓ | Tesaro INC | -0.8% | -84.57% | Trim |
| 20 | HCA | HCA Healthcare, Inc. | -1.6% | -17.34% | Trim |
| 21 | BIIB | Biogen Inc. | -1.6% | -64.26% | Trim |
| 22 | ABBV | AbbVie Inc. | -4.8% | -77.03% | Trim |
| 23 | SPY | State Street SPDR S&P 500 ETF Trust | — | NEW | New buy |
| 24 | ✓ | Ishares Tr | — | NEW | New buy |
| 25 | ✓ | Ishares Tr | — | EXIT | Sold out |
| 26 | GILD | Gilead Sciences, Inc. | — | NEW | New buy |
| 27 | ✓ | Ishares Tr | — | NEW | New buy |
| 28 | AMGN | Amgen Inc. | — | EXIT | Sold out |
| 29 | AMGN | Amgen Inc. | — | NEW | New buy |
| 30 | PFE | Pfizer Inc. | — | EXIT | Sold out |
| 31 | JNJ | Johnson & Johnson | — | EXIT | Sold out |
| 32 | DXCM | DexCom, Inc. | — | EXIT | Sold out |
| 33 | BMY | Bristol-Myers Squibb Company | — | NEW | New buy |
| 34 | MRK | Merck & Co., Inc. | — | NEW | New buy |
| 35 | ✓ | Acadia Healthcare Company In | — | NEW | New buy |
| 36 | ✓ | Agios Pharmaceuticals INC | — | NEW | New buy |
| 37 | AXP | American Express Company | — | NEW | New buy |
| 38 | BMY | Bristol-Myers Squibb Company | — | NEW | New buy |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | — | EXIT | Sold out |
| 40 | ✓ | Acadia Pharmaceuticals INC | — | EXIT | Sold out |
| 41 | ✓ | United Therapeutics CORP Del | — | NEW | New buy |
| 42 | GLD | SPDR Gold Shares | — | EXIT | Sold out |
| 43 | HUM | Humana Inc. | — | NEW | New buy |
| 44 | AXP | American Express Company | — | NEW | New buy |
| 45 | AZN | AstraZeneca PLC | — | NEW | New buy |
| 46 | HESM | Hess Midstream LP | — | NEW | New buy |
| 47 | ✓ | Bluebird Bio INC | — | NEW | New buy |
| 48 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 49 | ✓ | Barclays Bk PLC | — | EXIT | Sold out |
| 50 | AMRN 3.5 01-15-32 2014 | Corsicanto LTD | — | EXIT | Sold out |